SLC29A1 and familial pancreatic carcinoma: In this study, we first verify the role of hENT1 as a prognostic predictor for pancreatic cancer patients who underwent radical surgery followed by intra-arterial infusion of gemcitabine-based chemotherapy, in order to select beneficiaries of this chemo-therapeutic strategy.